{
  "docId": "019dd923-622c-750b-8b9a-36086e11ebef",
  "docSlug": "85d06cb9f231",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "regulatory-filing",
  "documentKindLabel": "Regulatory filing",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-21 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 2,
  "pageCount": 10,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "This is a text-heavy regulatory filing document, likely part of a petition to the FDA regarding safety concerns.",
  "elementsJson": [
    "paragraph"
  ],
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-36086e11ebef/2",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-36086e11ebef",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-36086e11ebef.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-36086e11ebef#slide-2",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The CEO declined to specifically detail the nature of the recent hospitalizations, indicating only that they were for pulmonary/respiratory events and “events related to hyperglycemia.”",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-14dc-7419-88c0-1721eb51a1f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.82,
        "w": 0.78,
        "x": 0.11,
        "y": 0.09
      },
      "kind": "paragraph",
      "text": "The CEO's talking points during these private investor forums... downplay these adverse events as being 'on label'...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8054c059-d618-4445-ba7e-6b25cab1402b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“the package insert specifically talks about all of these things...the idea is that physicians need to take care of that.” — Soleno CEO; “so far, the company has received reports of 7 patients experiencing SAE\"s that led to hospitalizations, out of hundreds of start forms (646 by June 30); all of these patients have since recovered.” — Guggenheim Securities (Aug 18, 2025: “Flash Note”/“SLNO: Notes from Mgmt/Investor Meetings”)",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-14dc-7419-88c0-1b8d986b96fd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "c3b7c57e-9579-4cb3-8822-71dc379b52e5",
      "evidence": "The text systematically exposes contradictions between company statements and reported safety data.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 2,
      "beatId": "69f60f3b-27cc-471c-aa78-ba0d72634363",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "Slides expose contradictions and highlight significant concerns regarding Soleno’s publications.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}